{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:32:33Z","timestamp":1790469153266,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1097\/md.0000000000000026","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T23:44:50Z","timestamp":1399333490000},"page":"143-149","source":"Crossref","is-referenced-by-count":86,"title":["Bloodstream Infections in Patients With Solid Tumors"],"prefix":"10.1097","volume":"93","author":[{"given":"Mar","family":"Mar\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Gudiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Garcia-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ardanuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Carratal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s15010-004-3049-5","article-title":"Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome.","volume":"32","author":"Anatoliotaki","year":"2004","journal-title":"Infection"},{"key":"R4-3-20210226","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/AAC.39.2.445","article-title":"The International Antimicrobial Therapy Cooperative Group of the EORTC. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer.","volume":"39","author":"Cometta","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-3-20210226","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMra020529","article-title":"Corticosteroid insufficiency in acutely ill patients.","volume":"348","author":"Cooper","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-3-20210226","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1099\/jmm.0.46747-0","article-title":"The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa.","volume":"55","author":"Falagas","year":"2006","journal-title":"J Med Microbiol"},{"key":"R7-3-20210226","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Infectious Diseases Society of America (2011) clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America.","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R8-3-20210226","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections.","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med"},{"key":"R9-3-20210226","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/AAC.01169-07","article-title":"Clinical and economic impact of common multidrug-resistant gram-negative bacilli.","volume":"52","author":"Giske","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-3-20210226","first-page":"241","article-title":"Identification of people with chronic advanced diseases and need of palliative care in sociosanitary sevices: elaboration of the NECPAL CCOMS-ICO tool.","volume":"140","author":"Gomez-Batiste","year":"2013","journal-title":"Med Clin (Barc)"},{"key":"R11-3-20210226","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s100960050345","article-title":"Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia.","volume":"18","author":"Gonzalez-Barca","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R13-3-20210226","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/jac\/dkq494","article-title":"Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.","volume":"66","author":"Gudiol","year":"2011","journal-title":"J Antimicrobial Chemother"},{"key":"R15-3-20210226","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.49.2.760-766.2005","article-title":"Bloodstream infections caused antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.","volume":"49","author":"Kang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-3-20210226","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1086\/383050","article-title":"Management of fever in neutropenic patients with different risks of complications.","volume":"39","author":"Klastersky","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"R17-3-20210226","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","article-title":"Bacteraemia in febrile neutropenia cancer patients.","volume":"30","author":"Klastersky","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"R18-3-20210226","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer Risk Index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients.","volume":"18","author":"Klastersky","year":"2000","journal-title":"J Clin Oncol"},{"key":"R19-3-20210226","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1600-6143.2008.02197.x","article-title":"Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation.","volume":"8","author":"Linares","year":"2008","journal-title":"Am J Transplant"},{"key":"R20-3-20210226","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","article-title":"Recent changes in bacteraemia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.","volume":"32","author":"Montassier","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R22-3-20210226","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bmt.1705677","article-title":"Epidemiology of bacteraemia and factors associated with multi-drug-resistant gram-negative bacteraemia in hematopoietic stem cell transplant recipients.","volume":"39","author":"Oliveira","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R23-3-20210226","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhin.2007.11.012","article-title":"Infections due to Escherichia coli producing extended-spectrum b-lactamase among hospitalised patients: factors influencing mortality.","volume":"68","author":"Pena","year":"2008","journal-title":"J Hosp Infect"},{"key":"R24-3-20210226","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10096-007-0320-6","article-title":"Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters.","volume":"26","author":"Raad","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R25-3-20210226","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Community-onset bacteraemia due to ESBL-EC: risk factors and prognosis.","volume":"50","author":"Rodriguez-Bano","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R26-3-20210226","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/jac\/dkt002","article-title":"Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance.","volume":"68","author":"Schelenz","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"R27-3-20210226","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum b-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.","volume":"60","author":"Schwaber","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R28-3-20210226","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s101560050031","article-title":"Bacteraemia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study.","volume":"5","author":"Spanik","year":"1999","journal-title":"J Infect Chemother"},{"key":"R29-3-20210226","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinf.2009.02.002","article-title":"Incidence and clinical impact of extended-spectrum-b-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with haematological malignancies.","volume":"58","author":"Trecarichi","year":"2009","journal-title":"J Infect"},{"key":"R30-3-20210226","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1473-3099(07)70265-7","article-title":"Host-pathogen interactions in sepsis.","volume":"8","author":"Van Der Poll","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"R31-3-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10096-005-0077-8","article-title":"Comparative study of clinical characteristics of neutropenia and non-neutropenia adult cancer patients with bloodstream infections.","volume":"25","author":"Velasco","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R32-3-20210226","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","article-title":"Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States.","volume":"36","author":"Wisplinghoff","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:36:49Z","timestamp":1620959809000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201405000-00003"}},"subtitle":["Epidemiology, Antibiotic Therapy, and Outcomes in 528 Episodes in a Single Cancer Center"],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000026","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}